Non-radiographic Axial Spondyloarthritis
📧 Sign up to get email alerts when something new happens for Non-radiographic Axial Spondyloarthritis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-21EMA Authorised: Gobivaz (golimumab) — Advanz Pharma Limited
Authorised status for Gobivaz (golimumab) by Advanz Pharma Limited for multiple inflammatory diseases, expanding label in Europe.
-
EMA approval · 2026-07-01EMA Authorised: Gotenfia (golimumab) — Stada Arzneimittel AG
European Medicines Agency authorised Gotenfia (golimumab) by Stada Arzneimittel AG for multiple inflammatory diseases including various form…
-
EMA approval · 2026-06-12EMA Authorised: Fubelv — Biosimilar Collaborations Ireland Limited
EMA has authorised Fubelv as a biosimilar, with indications across various inflammatory arthritis and psoriasis conditions.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission [Phase 4]
A Phase 4 study evaluating whether Secukinumab (Cosentyx) maintains remission in adults with non-radiographic axial spondyloarthritis. The t…
-
EMA approval · 2026-02-25EMA Authorised: Gotenfia (golimumab) — Stada Arzneimittel AG
The EMA authorised Gotenfia (golimumab) by Stada Arzneimittel AG for multiple inflammatory diseases, including rheumatoid arthritis, juvenil…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Efficacy and Safety Study of Secukinumab in Chinese Participants With Non-radiographic Axial Spondyloarthritis [Phase 3]
This document reports the completion of a Phase 3 efficacy and safety study of Secukinumab in Chinese participants with non-radiographic axi…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis [Phase 2, Phase 3]
Trial update on Xeligekimab for non-radiographic axial spondyloarthritis; Phase 2/3 study assessing efficacy and safety. The study is curren…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: 2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis
A completed two-year real-world study assessing retention, quality of life, effectiveness and treatment patterns of secukinumab in adults wi…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
A ClinicalTrials.gov update describes a biospecimen collection study led by TScan Therapeutics to identify targets of disease-reactive T cel…
-
EMA approval · 2025-11-20EMA Authorised: Gobivaz (golimumab) — Advanz Pharma Limited
The EMA authorised Gobivaz (golimumab) for multiple inflammatory diseases. Indications include rheumatoid arthritis, juvenile idiopathic art…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpA
This clinical trial is recruiting to assess whole-body MRI for non-invasive lesion detection and therapy follow-up in patients with axial sp…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA) [Phase 2]
A Phase 2 clinical trial evaluating the compound 608 in non-radiographic axial spondyloarthritis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: A LONGITUDINAL OBSERVATIONAL STUDY to EVALUATE the EFFICACY of MOVEMENT and IMPLEMENT CONCRETE MOVEMENT RECOMMENDATIONS with the HELP of MOBILITY TRACKING with SMARTWATCHES in SUBJECTS with AXIAL SPONDYLOARTHRITIS
A longitudinal observational study evaluating whether movement guidance and smartwatch-based mobility tracking improve outcomes in axial spo…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Registry study evaluating patient-reported outcomes, dosing patterns, and safety of Vunakizumab in several rheumatic diseases; recruitment h…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Osteosarcopenia in Axial Spondyloarthritis
This ClinicalTrials.gov entry reports that Ankara University is recruiting participants for a study on osteosarcopenia in axial spondyloarth…
-
FDA approval · 2023-11-20FDA Tentative Approval: TALTZ — Supplemental Application (Eli Lilly and Company)
The FDA issued tentative approval for a supplemental application for TALTZ (ixekizumab) by Eli Lilly, indicating the submission is approvabl…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis [Phase 2]
This Phase 2 trial update reports results from a study evaluating the effect of Filgotinib on semen parameters in adult males with active rh…
-
FDA approval · 2023-07-24FDA Approved: COSENTYX — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Cosentyx (secukinumab) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis [Phase 3]
Phase 3 clinical trial evaluating SHR0302 for non-radiographic axial spondyloarthritis; status and results not specified.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active Nr-axSpA [Phase 2]
Phase 2 study evaluating preliminary efficacy, safety, and pharmacokinetics of subcutaneous JS005 in Chinese adults with active non-radiogra…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Efficacy and Safety Study of SUNPG1622 [Phase 2]
Phase 2 clinical trial update for SUNPG1622 in active ankylosing spondylitis or non-radiographic axial spondyloarthritis; study terminated w…
-
FDA approval · 2020-06-16FDA Approved: COSENTYX — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Cosentyx (secukinumab) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta [Phase 1]
Phase 1 postmarketing transfer study evaluating Cimzia (certolizumab pegol) from mother to infant via placenta has completed with results po…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis [Phase 3]
A Phase 3 clinical trial evaluating whether continuing versus withdrawing adalimumab maintains remission in non-radiographic axial spondyloa…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers [Phase 1]
A multicenter Phase 1 postmarketing study evaluating the concentration of certolizumab pegol (Cimzia) in mature breast milk of lactating mot…